Beta Bionics, Inc. financial data

Symbol
BBNX on Nasdaq
Location
Irvine, CA
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 24 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1177% %
Quick Ratio 81% %
Debt-to-equity 11% %
Return On Equity -24% % -202%
Return On Assets -22% %
Operating Margin -72% % -2.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 44,382,146 shares 2.4%
Common Stock, Shares, Outstanding 44,360,873 shares 565%
Entity Public Float $631,998,349 USD
Common Stock, Value, Issued $4,000 USD 300%
Weighted Average Number of Shares Outstanding, Basic 40,529,051 shares 537%
Weighted Average Number of Shares Outstanding, Diluted 40,529,051 shares 537%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $100,251,000 USD 54%
Research and Development Expense $34,789,000 USD 33%
Selling and Marketing Expense $61,404,000 USD 66%
General and Administrative Expense $31,025,000 USD 74%
Operating Income (Loss) $71,681,000 USD -58%
Nonoperating Income (Expense) $1,519,000 USD 84%
Net Income (Loss) Attributable to Parent $73,200,000 USD -34%
Earnings Per Share, Basic -1.81 USD/shares 79%
Earnings Per Share, Diluted -1.81 USD/shares 79%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $31,576,000 USD 3.8%
Accounts Receivable, after Allowance for Credit Loss, Current $17,118,000 USD 43%
Inventory, Net $21,722,000 USD 63%
Other Assets, Current $265,000 USD
Assets, Current $267,905,000 USD 102%
Property, Plant and Equipment, Net $8,600,000 USD 80%
Operating Lease, Right-of-Use Asset $6,627,000 USD -0.27%
Other Assets, Noncurrent $180,000 USD 20%
Assets $328,743,000 USD 120%
Accounts Payable, Current $4,998,000 USD 75%
Employee-related Liabilities, Current $12,656,000 USD 27%
Liabilities, Current $30,924,000 USD 46%
Operating Lease, Liability, Noncurrent $5,365,000 USD -6.3%
Other Liabilities, Noncurrent $1,547,000 USD
Liabilities $41,133,000 USD -44%
Accumulated Other Comprehensive Income (Loss), Net of Tax $403,000 USD 520%
Retained Earnings (Accumulated Deficit) $369,937,000 USD -25%
Stockholders' Equity Attributable to Parent $287,610,000 USD
Liabilities and Equity $328,743,000 USD 120%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $19,975,000 USD -64%
Net Cash Provided by (Used in) Financing Activities $211,119,000 USD
Net Cash Provided by (Used in) Investing Activities $179,122,000 USD -2443%
Common Stock, Shares Authorized 700,000,000 shares 0%
Common Stock, Shares, Issued 44,360,873 shares 565%
Common Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $12,022,000 USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $31,676,000 USD 3.7%
Deferred Tax Assets, Valuation Allowance $75,307,000 USD 23%
Deferred Tax Assets, Gross $77,147,000 USD 23%
Operating Lease, Liability $7,303,000 USD 0.66%
Depreciation $303,000 USD 5.6%
Payments to Acquire Property, Plant, and Equipment $333,000 USD -18%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $72,862,000 USD -33%
Lessee, Operating Lease, Liability, to be Paid $8,818,000 USD -3.1%
Property, Plant and Equipment, Gross $14,355,000 USD 43%
Operating Lease, Liability, Current $1,938,000 USD 27%
Lessee, Operating Lease, Liability, to be Paid, Year Two $1,418,000 USD -7.4%
Lessee, Operating Lease, Liability, to be Paid, Year One $2,006,000 USD 27%
Operating Lease, Weighted Average Discount Rate, Percent 0.068 pure 1.6%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $1,515,000 USD -18%
Lessee, Operating Lease, Liability, to be Paid, Year Three $1,384,000 USD 49%
Deferred Tax Assets, Operating Loss Carryforwards $54,762,000 USD 39%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Unrecognized Tax Benefits $1,969,000 USD 41%
Lessee, Operating Lease, Liability, to be Paid, Year Four $1,092,000 USD 4%
Operating Lease, Payments $400,000 USD 33%
Additional Paid in Capital $657,140,000 USD 1181%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance $1,840,000 USD 14%
Share-based Payment Arrangement, Expense $16,384,000 USD 157%
Preferred Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%